Multiple Sclerosis: Pathology

Multiple Sclerosis (MS) is a demyelinating autoimmune disease of the central nervous system. Symptoms include optic neuritis and motor weakness. Here is the latest research on the pathology of this complex neurodegenerative disease.

January 16, 2022

Impact of intestinal disorders on central and peripheral nervous system diseases.

Neurobiology of Disease
Yumna El-HakimFarida Sohrabji
January 16, 2022

Fingolimod Rescues Memory and Improves Pathological Hallmarks in the 3xTg-AD Model of Alzheimer's Disease.

Molecular Neurobiology
Steven G FaganKumlesh K Dev
January 15, 2022

[Effectiveness of sacral neuromodulation in patients with Parkinson's disease].

Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie
C MilletL Guy
January 15, 2022

Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.

Neurology. Neuroimmunology and Neuroinflammation
Jana RemlingerAnke Salmen
January 14, 2022

Hemispherectomy for hemimegalencephaly in a 6.5-week-old infant with tuberous sclerosis complex.

Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery
Demitre SerletisMarc R Del Bigio
January 12, 2022
Open Access

MiR-155: An Important Regulator of Neuroinflammation.

International Journal of Molecular Sciences
Valeria Domenica ZingaleEmanuela Mazzon
January 12, 2022

Cannabinoids in Breast Cancer: Differential Susceptibility According to Subtype.

Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry
Cristina Ferreira AlmeidaCristina Amaral
January 12, 2022

Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.

Molecular Neurobiology
Samridhi SharmaVivek Gupta
January 11, 2022

Multiple variants of soluble CD146 are involved in Systemic Sclerosis: identification of a novel pro-fibrotic factor.

Arthritis & Rheumatology
Marie NolletMarcel Blot-Chabaud
January 11, 2022
Open Access

Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.

Frontiers in Neuroscience
Bridget C BensonGuillaume M Hautbergue
January 11, 2022

A Review on the Mechanism and Application of Keishibukuryogan.

Frontiers in Nutrition
Koichiro TanakaKazuhiko Nara
January 11, 2022
Open Access

Extracellular vesicles (exosomes and ectosomes) play key roles in the pathology of brain diseases.

Molecular Biomedicine
Jacopo Meldolesi
January 7, 2022

The Effects of Modified Curcumin Preparations on Glial Morphology in Aging and Neuroinflammation.

Neurochemical Research
Faheem UllahErika Gyengesi
January 6, 2022

Liraglutide attenuate central nervous inflammation and demyelination through AMPK and pyroptosis-related NLRP3 pathway.

CNS Neuroscience & Therapeutics
Shuang SongBin Li

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.


TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Acute Disseminated Encephalomyelitis

Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory demyelinating disease of the central nervous system. Discover the latest research on acute disseminated encephalomyelitis here.

Acute Hemorrhagic Leukoencephalitis

Acute hemorrhagic leukoencephalitis is a rare form of acute disseminated encephalomyelitis characterized by acute inflammation in the brain and spinal cord that causes demyelination and bleeding. It is often fatal, although treatment with immunosuppressives and plasma exchange can be helpful. Find the latest research on acute hemorrhagic leukoencephalitis here.

© 2022 Meta ULC. All rights reserved